巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    argenx SE

    ARGX
    357.250
    0.250
    0.07%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・argenx SE - 延遲價格・最後更新於 29/09 12:00
    最高位
    358.260
    最低位
    350.940
    開市價
    --
    前收市價
    357.500
    成交量(千)
    4.08
    成交額(百萬)
    13.64
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    19,670.72
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    403.770 - 249.500
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    argenx SE
    證券代碼
    ARGX.US
    所屬板塊
    Biotechnology
    公司業務
    argenx SE is an immunology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group has partnered with academic researchers through its Immunology Innovation Program (IIP) and aims to translate immunology breakthroughs into a portfolio of novel antibody-based medicines. argenx developed and is commercializing the neonatal Fc receptor (FcRn) blocker in the U.S., Japan, and the EU. Its product pipeline includes product candidates such as ARGX-117, ARGX-118, ARGX-115, ARGX-116, and others.
    發行量
    55061502
    公司總部
    Willemstraat 5
    公司網址
    https://www.argenx.com
    公司電郵
    info@argenx.com
    公司電話
    +31 763030488
    暫無內容

    關於

    argenx SE(ARGX.US)所屬的行業板塊為Biotechnology。
    argenx SE is an immunology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group has partnered with academic researchers through its Immunology Innovation Program (IIP) and aims to translate immunology breakthroughs into a portfolio of novel antibody-based medicines. argenx developed and is commercializing the neonatal Fc receptor (FcRn) blocker in the U.S., Japan, and the EU. Its product pipeline includes product candidates such as ARGX-117, ARGX-118, ARGX-115, ARGX-116, and others.
    詳細公司背景可參考: https://www.argenx.com